Skip to main content

HIV-1 Related Central Nervous System Diseases: Pathogenesis, Diagnosis, and Treatment – An Indian Scenario

  • 693 Accesses

Abstract

In the past several decades, various advances in medical sciences have improved the care of HIV-infected individuals globally. With the advent of antiretroviral therapy (ARV), the incidence of neurological opportunistic infections has been greatly reduced. However, the nonopportunistic condition like neurocognitive impairment is still prevalent among HIV-infected individuals. The studies from India conducted in late 1990s on neurological aspects of HIV have mostly concentrated on dementia or AIDS dementia complex. Over time, the neurocognitive consequences of HIV have gained the attention of Indian clinicians as they impair the quality of life, every day activities, employment, and adherence to the treatment. Despite the fact that the recent gains have increased the focus on the assessment of neurocognitive disorders associated with HIV, the data in India are meager. An attempt has been made in this chapter to analyze and present various central nervous system diseases associated with HIV-1 infection, prevalent in India, grounded on various hospital-based reports covering the country.

Keywords

  • India
  • HIV
  • NeuroAIDS
  • Neurological complications
  • Dementia
  • Antiretroviral therapy
  • Adherence to treatment
  • Follow-up
  • Opportunistic infections
  • Toxoplasmosis
  • Cryptococcal meningitis
  • TB
  • PML
  • Seizures
  • Central nervous system lymphoma
  • Non-Hodgkin’s lymphoma
  • Hospital-based reports

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4939-7290-6_3
  • Chapter length: 11 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   299.00
Price excludes VAT (USA)
  • ISBN: 978-1-4939-7290-6
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   379.99
Price excludes VAT (USA)
Hardcover Book
USD   379.99
Price excludes VAT (USA)

Notes

  1. 1.

    http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf.

  2. 2.

    https://www.ncbi.nlm.nih.gov/pubmed/?term=neuroaids++india.

  3. 3.

    https://radiopaedia.org/articles/blooming-artifact.

  4. 4.

    http://library.med.utah.edu/WebPath/AIDS2016.PDF.

References

  1. Solomon S, Chakraborty A, Yepthomi RD, Detels R (2004) A review of the HIV epidemic in India. AIDS Educ Prev 16(Suppl A):155–169

    CrossRef  PubMed  Google Scholar 

  2. Gray F, Gherardi R, Scaravilli F (1988) The neuropathology of the acquired immune deficiency syndrome (AIDS). A review. Brain J Neurol 111(Pt 2):245–266

    CrossRef  Google Scholar 

  3. Patrick MK, Johnston JB, Power C (2002) Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility. J Virol 76(16):7923–7931

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  4. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83(18):7089–7093

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  5. Kaul M, Lipton SA (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4(3):307–318

    CAS  CrossRef  PubMed  Google Scholar 

  6. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC et al (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65–70

    CrossRef  PubMed  PubMed Central  Google Scholar 

  7. Kongsiriwattanakul S, Suankratay C (2011) Central nervous system infections in HIV-infected patients hospitalized at King Chulalongkorn Memorial Hospital. J Med Assoc Thai Chotmaihet Thangphaet 94(5):551–558

    PubMed  Google Scholar 

  8. Bhigjee AI (2005) Neurological manifestations of HIV infection in Kwazulu-Natal South Africa. J Neurovirol 11(Suppl 1):17–21

    PubMed  Google Scholar 

  9. Asselman V, Thienemann F, Pepper DJ, Boulle A, Wilkinson RJ, Meintjes G et al (2010) Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS Lond Engl 24(18):2871–2876

    CrossRef  Google Scholar 

  10. Nakasujja N, Musisi S, Robertson K, Wong M, Sacktor N, Ronald A (2005) Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol 11(Suppl 3):26–29

    CrossRef  PubMed  Google Scholar 

  11. McArthur JC (2004) HIV dementia: an evolving disease. J Neuroimmunol 157(1–2):3–10

    CAS  CrossRef  PubMed  Google Scholar 

  12. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121

    CAS  CrossRef  PubMed  Google Scholar 

  13. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN et al (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56(2):257–260

    CAS  CrossRef  PubMed  Google Scholar 

  14. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E et al (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5):350–355

    CAS  CrossRef  PubMed  Google Scholar 

  15. d’Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J (2004) Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 55(3):320–328

    CrossRef  PubMed  Google Scholar 

  16. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17(10):1539–1545

    CrossRef  PubMed  Google Scholar 

  17. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C (2001) Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20(4):146–155

    CAS  PubMed  Google Scholar 

  18. May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R (2007) Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol 2(1):97–104

    CrossRef  PubMed  Google Scholar 

  19. Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004) Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36(1):562–566

    CrossRef  PubMed  Google Scholar 

  20. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311–314

    CAS  CrossRef  PubMed  Google Scholar 

  21. Lanjewar DN, Jain PP, Shetty CR (1998) Profile of central nervous system pathology in patients with AIDS: an autopsy study from India. AIDS Lond Engl 12(3):309–313

    CAS  CrossRef  Google Scholar 

  22. Patil VC, Patil HV (2014) Neurological manifestations of HIV-AIDS at a tertiary care center in western Maharashtra. Int J Med Public Health 4:210–217

    CrossRef  Google Scholar 

  23. Dubé MP, Holtom PD, Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93(5):520–524

    CrossRef  PubMed  Google Scholar 

  24. Baradkar V, Mathur M, De A, Kumar S, Rathi M (2009) Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients. Indian J Sex Transm Dis 30(1):19–22

    CrossRef  PubMed  PubMed Central  Google Scholar 

  25. Jaiswal SPB, Hemwani N, Sharma N, Athale S, Chitnis DS (2002) Prevalence of fungal meningitis among HIV positive & negative subjects in Indore (MP state). Indian J Med Sci 56(7):325–329

    CAS  PubMed  Google Scholar 

  26. Sinha S, Satishchandra P, Nalini A, Ravi V, Subbakrishna DK, Jayakumar PN, Chandramukhi A, Shankar SK (2005) New-onset seizures among HIV infected drug naïve patients from south India. Neurol Asia 10:29–33

    Google Scholar 

  27. Garg RK (1999) HIV infection and seizures. Postgrad Med J 75(885):387–390

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  28. Satishchandra P, Sinha S (2008) Seizures in HIV-seropositive individuals: NIMHANS experience and review. Epilepsia 49(Suppl 6):33–41

    CrossRef  PubMed  Google Scholar 

  29. Brew BJ (2001) HIV neurology. Oxford University Press, Oxford, NY

    Google Scholar 

  30. Riedel D, Ghate M, Nene M, Paranjape R, Mehendale S, Bollinger R et al (2006) Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol 12(1):34–38

    CAS  CrossRef  PubMed  Google Scholar 

  31. Saini S, Barar KV (2014) Assessment of neurocognitive functions in HIV/AIDS patients on HAART using the international HIV dementia scale. Int J Nutr Pharmacol Neurol Dis 4(4):252

    CrossRef  Google Scholar 

  32. Clifford DB (1999) Focal Brain Lesions in People with HIV. Curr Treat Options Neurol 1(2):167–172

    CAS  CrossRef  PubMed  Google Scholar 

  33. Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J et al (2008) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill, New York, p 2961

    Google Scholar 

  34. Anuradha B, Preethi C (2014) Seroprevalence of Toxoplasma IgG antibodies in HIV positive patients in and around Khammam, Telangana State. J Clin Diagn Res JCDR 8(9):DL01–DL02

    PubMed  Google Scholar 

  35. Sucilathangam G, Palaniappan N, Sreekumar C, Anna T (2013) Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study. Indian J Med Res 137(3):560–563

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Meisheri YV, Mehta S, Patel UA (1997) prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med 43(4):93–97

    CAS  PubMed  Google Scholar 

  37. Ashok Kumar EA, Jijiya Bai P (2016) A clinical study of CNS Tuberculomas. IAIM 3(6):101–106

    Google Scholar 

  38. Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK (2005) Primary central nervous system lymphoma--a hospital based study of incidence and clinicopathological features from India (1980-2003). J Neurooncol 71(2):199–204

    CrossRef  PubMed  Google Scholar 

  39. Powari M, Radotra B, Das A, Banerjee AK (2002) A study of primary central nervous system lymphoma in northern India. Surg Neurol 57(2):113–116

    CrossRef  PubMed  Google Scholar 

  40. Arvind G, Evangelyne S, Limanukshi A, Devi SB, Singh WJ (2013) Human immunodeficiency virus-associated stroke: an aetiopathogenesis study. J Assoc Physicians India 61(11):793–797

    CAS  PubMed  Google Scholar 

  41. Dobbs MR, Berger JR (2009) Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 7(10):1263–1271

    CrossRef  PubMed  Google Scholar 

  42. Factor SA, Troche-Panetto M, Weaver SA (2003) Dystonia in AIDS: report of four cases. Mov Disord Off J Mov Disord Soc 18(12):1492–1498

    CrossRef  Google Scholar 

  43. Satishchandra P (2010) Thomas Mathew. Neurological manifestations associated with HIV infection: Indian perspective. J Assoc Physicians India 14(8):760–765

    Google Scholar 

  44. Babu PG, Gnanamuthu C, Saraswathi NK, Nerurkar VR, Yanagihara R, John TJ (1993) HTLV-I-associated myelopathy in south India. AIDS Res Hum Retroviruses 9(6):499–500

    CAS  CrossRef  PubMed  Google Scholar 

  45. Babu PG, Ishida T, Nesadoss J, John TJ (1995) Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India. Scand J Infect Dis 27(2):105–108

    CAS  CrossRef  PubMed  Google Scholar 

  46. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD (2000) The clinical, radiological and pathological profile of tuberculous meningitis in 2000 patients with and without human immunodeficiency virus infection. J Neurol Sci 181:118–126

    CAS  CrossRef  PubMed  Google Scholar 

  47. Anita M, Sanjib S, Netravathi M, Satishchandra P, Shankar SK (2015) Subacute and chronic viral infections of nervous system and prion diseases. In: Wadia NH, Khadilkar SV (eds) Neurological practice, vol 2. Elsevier, New Delhi, pp 57–115

    Google Scholar 

  48. Shankar SK, Satishchandra P, Mahadevan A, Yasha TC, Nagaraja D, Taly AB, Prabhakar S, Nath A (2003) Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neurovirol 1:59–67

    CrossRef  Google Scholar 

  49. Vijay DT, Talasila SR, Lakshmi V (2005) Neurologic manifestations of HIV infection: an Indian hospital-based study. AIDS Read 15:139–145

    Google Scholar 

  50. Sonkar SK, Gupta A, Atam V, Chaudhary SC, Tripathi AK, Sonkar GK (2012) Clinical profile of neurological manifestation in Human Immunodeficiency Virus-positive patients. N Am J Med Sci 4:596–599

    CrossRef  PubMed  PubMed Central  Google Scholar 

  51. Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001) Neurological manifestations of HIV disease. J Assoc Physicians India 49:343–348

    CAS  PubMed  Google Scholar 

  52. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK (2000) Profile of neurological disorders associated with HIV/AIDS from Bangalore, South India (1989-1996). Indian J Med Res 111:14–23

    CAS  PubMed  Google Scholar 

  53. Deshpande AK, Patnaik MM (2005) Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study. Med Gen Med 7(4):2

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohanapriya Arumugam .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Sundarrajan, S., Lulu, S., Arumugam, M. (2017). HIV-1 Related Central Nervous System Diseases: Pathogenesis, Diagnosis, and Treatment – An Indian Scenario. In: , et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_3

Download citation